Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
NCT00557232
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Rubeosis Iridis
Interventions
DRUG:
bevacizumab
Sponsor
Instituto de Olhos de Goiania